Nama's AI scorecard currently rates GE HealthCare Technologies Buy (5.8 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is GEHC's P/E ratio?

GE HealthCare Technologies trades at a trailing price-to-earnings ratio of 16.8.

When does GEHC report earnings?

GE HealthCare Technologies's next scheduled report is on Feb 3, 2027. Analysts expect EPS of $1.56.

What is the GEHC price target?

The median analyst price target from 20 analysts is $88.50, with a range of $75.00 – $100.00.

Is GEHC Shariah compliant?

Nama's AAOIFI-style screen reads GE HealthCare Technologies as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.

Does GEHC pay a dividend?

Yes — GE HealthCare Technologies's dividend yield is 0.2%.

Nama Insights

GE HealthCare Technologies (GEHC)

Healthcare · Medical Devices · NASDAQ

S&P 500Nasdaq-100

GE HealthCare Technologies (GEHC) is a Healthcare company in the Medical Devices industry. It has a market capitalization of $37.25B, a trailing price-to-earnings ratio of 16.8 and a free-cash-flow yield of 4.0%. Over the most recent reported fiscal year, revenue grew 4.8% and free cash flow per share fell 2.7%. Nama's AI scorecard rates it Buy, 5.8 out of 10. On 12-month momentum it ranks in the lagging band of its market.

AI scorecard

Buy · 5.8/10

Positive, at the low end of Buy. As of Nov 7, 2026.

Momentum

Lagging · -12.8% over 12 months ex. last

Second-worst fifth of its market on the past year's move.

Shariah screen

Shariah Compliant

Passes our debt, cash and income screen; not a scholar's ruling.

Off its high

-13.1%

How far the last close sits under the highest price of the past five years.

Market cap	$37.25B
Trailing P/E	16.8
Price / book	3.2
Price / sales	1.7
FCF yield	4.0%
Dividend yield	0.2%
Gross margin	39.9%
Operating margin	13.3%
Net margin	9.9%
Revenue growth (YoY)	+4.8%
Revenue growth (3-yr annual)	+4.0%
EPS growth (YoY)	+2.0%
FCF/share growth (YoY)	-2.7%
Beta	0.8
Exchange	NASDAQ
Sector	Healthcare
Industry	Medical Devices

GEHC earnings

Next report: Feb 3, 2027 (Q4 2026, EPS estimate $1.56). Beat the EPS estimate in 3 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q3 2026	Oct 28, 2026	$1.34	$1.20	+11.7%	$5.51B
Q2 2026	Jul 29, 2026	$1.13	$1.04	+8.7%	$5.29B
Q1 2026	Apr 29, 2026	$0.99	$1.05	-5.7%	$5.13B
Q4 2025	Feb 4, 2026	$1.44	$1.40	+2.9%	$5.70B

GEHC analyst price target

Median target $88.50 from 20 analysts, ranging $75.00 – $100.00.

Medical Devices peers

Ticker	Company	Market cap	P/E
ABT	Abbott Laboratories	$190.39B	20.4
MDT	Medtronic	$130.22B	17.8
SYK	Stryker	$124.06B	22.8
BSX	Boston Scientific	$61.96B	13.4
EW	Edwards Lifesciences	$58.73B	34.7
PHG	Koninklijke Philips	$29.67B	15.2
DXCM	DexCom	$29.62B	29.7
STE	STERIS	$24.60B	23.2

Explore live GEHC data on Nama Insights →

Recent Congressional trades

GE HealthCare Technologies trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Alan Armstrong	Senate	Buy	$1,001 - $15,000	Jul 21, 2026
Terri A. Sewell	House	Sell	$1,001 - $15,000	Apr 21, 2026
Warren Davidson	House	Sell	$1,001 - $15,000	Mar 25, 2026
Austin Scott	House	Sell	$1,001 - $15,000	Aug 13, 2025
Rob Bresnahan	House	Buy	$1,001 - $15,000	May 31, 2025
Rob Bresnahan	House	Sell	$1,001 - $15,000	Apr 28, 2025
Rob Bresnahan	House	Buy	$1,001 - $15,000	Mar 27, 2025

GEHC FAQ

Is GEHC a buy?: Nama's AI scorecard currently rates GE HealthCare Technologies Buy (5.8 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is GEHC's P/E ratio?: GE HealthCare Technologies trades at a trailing price-to-earnings ratio of 16.8.
When does GEHC report earnings?: GE HealthCare Technologies's next scheduled report is on Feb 3, 2027. Analysts expect EPS of $1.56.
What is the GEHC price target?: The median analyst price target from 20 analysts is $88.50, with a range of $75.00 – $100.00.
Is GEHC Shariah compliant?: Nama's AAOIFI-style screen reads GE HealthCare Technologies as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.
Does GEHC pay a dividend?: Yes — GE HealthCare Technologies's dividend yield is 0.2%.